Schedule 13G ownership disclosure
BENITEC BIOPHARMA INC
Security class unavailable · CUSIP: 08205P100
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.8200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-002807
- Form type
- SC 13G
- Filer
- ALPHA CAPITAL ANSTALT
- CIK
- CIK 1140358
- Filed
- Jan 19, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership